Speakers

Adam Savitz

Chief Medical Officer

Alto Neuroscience

Andrew Miller

Founder & President, Research & Development

Karuna Therapeutics

Cheryl Corcoran

Professor

Icahn School of Medicine at Mount Sinai

Hadile Ounallah Saad

Head of Innovation & Early-Stage Pipeline

Clexio Biosciences

Hannah Brown

Clinical Associate Professor, Psychiatry

Boston University (Researcher for Phase 3 Adjunctive KarXT trial)

Harri Jarvelainen

Chief Executive Officer

Aivo Biosciences

Jenny Barnett

Chief Executive Officer

Monument Therapeutics

Jonathan Javitt

Founder, Chairman & Chief Executive Officer

NRx Pharmaceuticals

Kiri Granger

Executive Director, Co-Founder & Chief Scientific Officer

Monument Therapeutics

Laxminarayan Bhat

President & Chief Executive Officer

Reviva Pharmaceuticals

Mathieu_Grace_Biotrial

Mathieu Grace

Feasibility and Proposal Manager

BioTrial

Mikhail Kalinichev neurosteryx

Mikhail Kalinichev

Head of Translational Science

Neurosterix

Neel Desai

Business Development & Licensing

Biogen

Nick Brandon

Chief Scientific Officer

Neumora

Pablo Lapuerta

Chief Executive Officer

4M Therapeutics Inc

Paulo Lizano

Divison Chief of Translational Neuroscience

Harvard Medical School

Robert Goldman

Senior Vice President, Head, Medical Affairs

MapLight Therapeutics

Shaheen Lakhan

Chief Medical Officer

Click Therapeutics

Stephanie McTighe - Innovation in Psychosis Therapeutics Summit

Stephanie McTighe

Senior Director, Pharmacology

Delix Therapeutics

Steven Paul

Founder & Board Chair

Seaport Therapeutics (former CEO & CSO of Karuna Therapeutics)

Zhong Zhong

Chief Scientific Officer

Ovid Therapeutics

Event Guide
Register